NCT00309621View on ClinicalTrials.gov

Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

May 31, 2007

Conditions
Hand Dermatoses
Interventions
DRUG

alitretinoin

Trial Locations (33)

12353

Berlin

13439

Berlin

14482

Potsdam

20246

Hamburg

20354

Hamburg

22143

Hamburg

23558

Lübeck

41061

Mönchengladbach

41747

Viersen

42275

Wuppertal

48143

Münster

49078

Osnabrück

49477

Ibbenbueren

51143

Cologne

60326

Frankfurt

69115

Abt. Klinische Sozialmedizin, Heidelberg

81375

München

T6G2G3

Edmonton

V5O3Y1

Vancouver

R3C1R4

Winnipeg

K6A1A1

Hawkesbury

N6H1S9

London

L3P1A8

Markham

L6J7W5

Oakville

H3X1V6

Montreal

J1H1Z1

Sheerbroke

G1J1X7

Québec

Unknown

Gdansk

Lublin

Szcecin

Wroclaw

31-462

Krakow

45-372

Opole

Sponsors
All Listed Sponsors
lead

Basilea Pharmaceutica

INDUSTRY